PENX News Alert Penford Corp (PENX) 18.80 12/16/2014 21:44:3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Penford Corp (PENX) 18.80 $PENX

Penford Products Launches New Biobased Deposition And Conditioning Polymer For Hair And Skin; Partners With Univar As Exclusive Distributor
PR Newswire - Thu Dec 11, 8:30AM CST
Penford Products, a division of Penford Corporation and a recognized leader in bioproducts innovation and applications development, announced today the introduction of PenCare(TM) DP, a new biobased deposition and conditioning polymer. To support the commercial introduction of PenCare DP, Penford has developed a strategic commercial relationship with exclusive distributor Univar Inc., a leading global chemical distributor of industrial and specialty chemicals.
PENX: 18.80 (-0.02)

Penford posts 4Q profit
Automated Insights - Thu Nov 13, 6:43PM CST
CENTENNIAL, Colo. (AP) _ Penford Corp. (PENX) on Thursday reported net income of $3 million, or 23 cents per share, in its fiscal fourth quarter.
PENX: 18.80 (-0.02)

Penford EPS of $0.23
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 4:35PM CST

PENX: 18.80 (-0.02)

Penford Reports Fourth Quarter and Fiscal Year 2014 Financial Results
Business Wire - Thu Nov 13, 3:30PM CST
--Full year diluted EPS increased to $0.60 from $0.32 in fiscal year 2013.
PENX: 18.80 (-0.02)

Global Hydrocolloids (Gelatin, Xanthan, Carrageenan, Alginate, Agar, Pectin, Guar, Locust Bean, Arabic, CMC) Market to 2019
M2 - Thu Nov 13, 5:21AM CST
Research and Markets (http://www.researchandmarkets.com/research/chkd85/hydrocolloids) has announced the addition of the "Hydrocolloids Market by Type, Source, F&B Application, Function & Geography - Global Trend & Forecast to 2019" report to their offering. The hydrocolloids market is projected to reach $7,911.1 million by 2019 with North America dominating the market in 2013 This report provides both, qualitative and quantitative analyses of the hydrocolloids market. It includes the market dynamics, trends, competitive strategies preferred by the key market players, the driving factors that boosted the growth, and the restraints in the market. The report also confers the opportunities in the hydrocolloids market for new entrants. Hydrocolloids have significant applications in baked goods, confectionery, meat & poultry, sauces & dressings, beverage, dairy products, baby foods, and prepared foods. In the food industry, hydrocolloids are used as emulsifiers, stabilizers, gelling agents, coating materials, and gelling agents to enhance the shelf life and texture of the product. The rising demand for healthy food products and preservation of parental drugs are some of the driving factors of the hydrocolloids market. However, the shortage of resources and vulnerability to seasonal changes are restraining the growth of the market. The continuous development in emerging markets, such as Brazil, Russia, India, and China is paving new opportunities for the hydrocolloids market. To maintain a competitive edge in the hydrocolloids market, the key players invest heavily in the launch and development of new products and technologies. Leading players such as CP Kelco (U.S.), DuPont (U.S.), Royal DSM (The Netherlands), Ashland (U.S.), and Kerry Group PLC (Ireland) have been profiled in the report. The report provides a complete analysis of the prominent companies and a chronology of developments with respect to new products/technologies launched and their applications. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Industry Trends 6 Market Overview 7 Hydrocolloids Market, By Type 8 Hydrocolloids Market, By Source 9 Hydrocolloids Market, By Function 10 Hydrocolloids Market, By Application 11 Hydrocolloids Market, By Geography 12 Competitive Landscape 13 Company Profiles - Ashland Inc. - CP Kelco - Cargill, Incorporated - E. I. Du Pont De Nemours and Company - Fuerst Day Lawson - Kerry Group Plc - Penford Corporation - Rousselot International - Royal DSM - Tic Gums Incorporation For more information visit http://www.researchandmarkets.com/research/ch...rocolloids
ASH: 115.09 (-0.34), PENX: 18.80 (-0.02)

Lifshitz & Miller Law Firm Announces Investigation of American Realty Capital Properties Inc., Covance Inc., Elecsys Corporation, ESB Financial Corporation, Hudson Valley Holding Corp., Monarch Community Bancorp, Inc., and Penford Corporation
PR Newswire - Wed Nov 05, 12:22PM CST
American Realty Capital Properties Inc.
ESBF: 18.23 (+0.25), ESYS: 17.21 (-0.13), PENX: 18.80 (-0.02), HVB: 25.78 (+0.19), ARCP: 7.70 (-0.53), CVD: 102.05 (+0.43)

LAWSUIT ALERT: Andrews & Springer LLC Announces That a Law Firm Has Filed a Class Action Lawsuit Against Penford Corporation - PENX
GlobeNewswire - Tue Nov 04, 5:02PM CST
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, announced today that a class action lawsuit has been filed on behalf of stockholders of Penford Corporation (Nasdaq ENX) ("Penford" or the "Company" seeking to challenge the Company's recently announced merger.
PENX: 18.80 (-0.02)

INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of Penford Corporation Regarding the Fairness of the Sale of the Company to Ingredion Incorporated - PENX
PR Newswire - Tue Nov 04, 11:04AM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Penford Corporation (NasdaqGM: PENX) ("Penford" in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 81.22 (-0.85), PENX: 18.80 (-0.02)

SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit In Connection With The Sale Of Penford Corporation
Business Wire - Mon Nov 03, 2:37PM CST
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Colorado on behalf of all common stockholders of Penford Corporation ("Penford" or the "Company" (Nasdaq: PENX) opposing the proposed acquisition of Penford by Ingredion Incorporated ("Ingredion" .
PENX: 18.80 (-0.02)

PENFORD CORPORATION SHAREHOLDER ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of Penford Corporation
GlobeNewswire - Mon Nov 03, 7:37AM CST
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Penford Corporation ("Penford" or the "Company" relating to the sale of the Company to Ingredion Incorporated ("Ingredion" . On October 15, 2014, the two companies announced the signing of a definitive merger agreement pursuant to which Ingredion will acquire Penford in a merger in a deal worth $340 million. As a result of the merger, Penford shareholders are only anticipated to receive $19 per share in cash in exchange for each share of Penford.
PENX: 18.80 (-0.02), DB: 30.07 (+0.08)

SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of Penford Corporation -- PENX
GlobeNewswire - Wed Oct 29, 12:04PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Colorado on behalf of all common stockholders of Penford Corporation ("Penford" or the "Company" (Nasdaq ENX) opposing the proposed acquisition of Penford by Ingredion Incorporated ("Ingredion" .
PENX: 18.80 (-0.02)

PENFORD CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Tue Oct 28, 10:55AM CDT
Rigrodsky & Long, P.A.:
INGR: 81.22 (-0.85), PENX: 18.80 (-0.02)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Penford Corporation of Class Action Against the Board of Directors of the Company Regarding the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
GlobeNewswire - Tue Oct 28, 10:29AM CDT
Levi & Korsinsky notifies investors of Penford Corporation ("Penford" or "the Company" (Nasdaq ENX) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Ingredion Incorporated (NYSE:INGR). A complaint was filed in Colorado federal court.
INGR: 81.22 (-0.85), PENX: 18.80 (-0.02)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Penford Corporation in Connection with the Sale of the Company
Business Wire - Mon Oct 27, 9:35PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Penford Corporation ("Penford" or the "Company" (Nasdaq: PENX) relating to the proposed acquisition by Ingredion Incorporated ("Ingredion" .
PENX: 18.80 (-0.02)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Penford Corporation Regarding the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
Business Wire - Mon Oct 27, 10:01AM CDT
Levi & Korsinsky is investigating the Board of Directors of Penford Corporation ("Penford" or "the Company" (NasdaqGM: PENX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 81.22 (-0.85), PENX: 18.80 (-0.02)

Law Offices of Marc S. Henzel Announces Securities Class Action Periods
PR Newswire - Mon Oct 27, 8:11AM CDT
The Law Offices of Marc S. Henzel (www.henzellaw.com) a firm focusing on shareholder litigation, gives notice to purchasers of the following securities for the following class periods:
ARWR: 5.86 (+0.41), WG: 5.00 (+0.99), RTRX: 11.12 (+0.56), PENX: 18.80 (-0.02), BBLU: 1.10 (+0.23), CNL: 54.16 (+0.23)

PENFORD CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Board of Directors of Penford Corporation (PENX) in Relation to the Proposed Sale of the Company to Ingredion Inc.
Business Wire - Fri Oct 24, 6:00PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Penford Corp. ("Penford" or the "Company" (NASDAQ ENX) for potential breaches of fiduciary duties in connection with the sale of the Company to Ingredion Inc. ("Ingredion" (INGR) for approximately $340 million. The Company's stockholders will only receive $19 for each share of Penford common stock they own.
PENX: 18.80 (-0.02)

INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Penford Corporation Concerning the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
PR Newswire - Mon Oct 20, 10:05AM CDT
Levi & Korsinsky is investigating the Board of Directors of Penford Corporation ("Penford" or "the Company" (NasdaqGM: PENX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 81.22 (-0.85), PENX: 18.80 (-0.02)

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Penford Corporation And Encourages Investors To Contact The Firm For Additional Information
Business Wire - Sun Oct 19, 5:28PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Penford Corporation ("Penford" or the "Company" (Nasdaq: PENX) relating to the proposed buyout of the Company by Ingredion Incorporated ("Ingredion" .
PENX: 18.80 (-0.02)

PENFORD CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Board of Directors of Penford Corporation in Relation to the Proposed Sale of the Company to Ingredion Inc. - PENX
PR Newswire - Fri Oct 17, 5:30PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Penford Corp. ("Penford" or the "Company" (NASDAQ: PENX) for potential breaches of fiduciary duties in connection with the sale of the Company to Ingredion Inc. ("Ingredion" (INGR) for approximately $340 million. The Company's stockholders will receive $19 for each share of Penford common stock they own.
PENX: 18.80 (-0.02)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 139

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
Nasdaq Tumbles: AI Hardware Pulls Markets Down

Updated Category News Views 184

Wall Street's Slide Fueled by AI Nerves The markets got a real jolt on Monday, sending Nasdaq down 2.5% thanks to a sharp dip in AI hardware stocks. Tech tickers tied to artificial intelligence were at the core of a sell-off, knocking the S&P 500 down 1.92% alongside it. Investors are on edge, and it’s not just the weather—it's a real shake-up driven by policy moves...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 207

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 146

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading
Québecor Makes Its Move: Eye on TELUS Amid Telecom Shakeup

Updated Category News Views 168

The Offer That Shocked the Telecom Markets Just when you think you’ve figured out the lay of the land, someone throws a curveball. Québecor’s decision to take a run at TELUS is shaking up Canada’s telecom scene big time. This isn’t just another M&A whisper; it’s a roaring freight train of a proposal valued at a whopping $31 billion. And TELUS, not just sitting...

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 108

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window

Updated Category News Views 79

A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 132

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 156

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading

Top 5 Most Recently Viewed Articles

James Lukezic's Triumph: FINRA Case Dismissed, Reputation Restored

Updated Category News Views 278

James Lukezic's Journey to Exoneration NEW YORK – After undergoing extensive hearings, James Lukezic, the Managing Principal of Old Slip Capital Management, has successfully cleared his name of unfounded allegations in a substantial FINRA case. This decision represents a significant milestone for Lukezic, who faced serious accusations surrounding five trades that...

Continue Reading
DraftKings Inc. Reports Impressive Q2 Growth and Strong Future Prospects

Updated Category News Views 175

DraftKings Inc. Achieves Record Revenue in Q2 DraftKings Inc. announced remarkable financial results for the second quarter, showcasing a significant leap in its performance. This includes a record revenue of $1.51 billion, representing a 37% increase year-over-year. This impressive growth surpassed analyst expectations, as the consensus estimate was only $1.39 billion....

Continue Reading
Trellis Bioscience's $9M Shot at Revolutionizing PJI Treatment

Updated Category News Views 40

New Hope on the Horizon for Joint Implant Infections When you hear about prosthetic joint infections (PJIs), 'devastating' doesn’t quite cover it. We’re talking something that’s hard to tackle, ends up costlier than a Beverly Hills tax bill, and drains quality of life like nothing else. Now, Trellis Bioscience seems to think there's hope on the way. The company just...

Continue Reading
Dionisio Gutiérrez Honored with Prestigious Award by Spain's King

Updated Category News Views 196

Dionisio Gutiérrez's Recognition and Achievements Dionisio Gutiérrez, a prominent figure known for his contributions to civic and business advancements, has recently been honored with the XI Enrique V. Iglesias Award. This prestigious accolade, presented by King Felipe VI of Spain, acknowledges Gutiérrez's significant impact within the Ibero-American space,...

Continue Reading
Vivani Medical Advances in Clinical Trials for GLP-1 Implant

Updated Category News Views 238

Vivani Medical, Inc. (NASDAQ: VANI) recently received approval from the Bellberry Human Research Ethics Committee and an acknowledgment from Australia’s Therapeutic Goods Administration for its first-in-human clinical trial. This significant step centers around the company's innovative GLP-1 (exenatide) implant targeting overweight and obese individuals, marking a...

Continue Reading